The bid to build a giant office and laboratory building near Central Square for Millennium Pharmaceuticals returned to the City Council on Monday with 168 units of affordable housing proposed to be preserved and 20 to be built, even as another 820 affordable-housing apartments are set to expire in roughly the next seven years.
Forest City Enterprises said today it is refiling a petition to build an office and laboratory building at 300 Massachusetts Ave. near Central Square, again for use by the pharmaceutical manufacturer Millennium Pharmaceuticals.
There’s only one thing standing between Biogen Idec returning to Cambridge, if a report from the Community Development Department is true: a zoning requirement putting a cafeteria on the ground floor of the biotech company’s headquarters and opening it to the public 20 hours a week.
Along with the rest of an exciting, arts-based vision for Central Square described Monday came a call for 1,000 units of housing to be built atop what are now parking lots or one- or two-story buildings.
Two Cambridge executives have won regional “Entrepreneur of the Year” designations from Ernst & Young.
Three Cambridge executives are finalists in the Ernst & Young Entrepreneur Of The Year New England Award.